MedTrace Logo

MH004 Ointment in Healthy Adult Volunteers and Participants With Mild to Moderate Atopic Dermatitis

NCT07182864 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2025-09-19

No results posted yet for this study

Summary

This is a Phase I/II Study of MH004 in Healthy Adult Volunteers, participants with Mild to Moderate Atopic Dermatitis.

Conditions

  • Atopic Dermatitis (AD)

Interventions

DRUG

MH004 0.1% Ointment

MH004 0.1% ointment applied topically to the affected area as a thin film.

DRUG

MH004 0.3% Ointment

MH004 0.3% ointment applied topically to the affected area as a thin film.

DRUG

MH004 1.0% Ointment

MH004 1.0% ointment applied topically to the affected area as a thin film.

DRUG

MH004 3.0% Ointment

MH004 3.0% ointment applied topically to the affected area as a thin film.

DRUG

Vehicle Ointment

Matching vehicle ointment applied topically to the affected area as a thin film.

Sponsors & Collaborators

  • Minghui Pharmaceutical (Hangzhou) Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-06
Primary Completion
2022-09-08
Completion
2022-10-08

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07182864 on ClinicalTrials.gov